.png)
DeepCure, California, United States
Derrick Miyao is the Vice President of Molecular Foundry at DeepCure and is a trailblazer in robotic synthesis and automated assays. Derrick joined DeepCure from Neurocrine Biosciences, where he spent 20 years creating systems for automated drug discovery, including building two systems that can synthesize up to 10,000 compounds a day and successfully integrate synthesis with affinity binding for closed discovery loop. At DeepCure, Derrick leads the Molecular Foundry, a fully automated synthesis and screening lab in Rehovot, Israel, that will unlock AI and chemistry to get better drugs to patients faster.
Disclosure information not submitted.
Automating Chemistry in the age of AI
Wednesday, February 7, 2024
12:30 PM – 2:30 PM EST